To enable their science to change the world, pharma companies need an in-depth understanding of their market, including doctors, potential patients, and payers, as well as a plan on how to navigate it most effectively. This includes understanding their target audience, as well as the relevant channels they need to utilize in order to engage with that audience.
Lessons from biopharmas taking a patient-first approach.
Verseon has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform. Financial terms were not disclosed.
Federal regulation of data privacy and security has been on the back burner for the past two years, but key members of Congress have been working behind the scenes to frame bipartisan legislation and the FTC is gearing up. The Supreme Court’s decision overturning Roe v. Wade may put this issue front and center in Congress after the midterms.